Research & Development

How Does Hartford HealthCare Define Excellence in Safety?
Research & Development How Does Hartford HealthCare Define Excellence in Safety?

In a landscape where healthcare providers strive for excellence, Hartford HealthCare (HHC) has distinguished itself by earning the 2025 AHA Quest for Quality Prize from the American Hospital Association. This accolade marks a significant achievement, underscoring their exceptional leadership,

CMS Launches Model for Greater Access to Gene Therapies
Research & Development CMS Launches Model for Greater Access to Gene Therapies

The Centers for Medicare & Medicaid Services (CMS) has taken a significant step in healthcare innovation by unveiling a pioneering model designed to improve access to advanced treatments for Medicaid patients affected by sickle cell disease. This initiative, focused on the Cell and Gene Therapy

Can SENP5 Structure Revolutionize Precision Medicine?
Research & Development Can SENP5 Structure Revolutionize Precision Medicine?

Imagine transforming today's healthcare challenges through cutting-edge scientific discovery, where diseases like cancer and cardiovascular disorders are seen as mere puzzles to solve. Within this realm of possibilities, the focus turns toward SENP5, a protease with the potential to illuminate new

How Can AI Safeguard Clinical Trial Innovations?
Research & Development How Can AI Safeguard Clinical Trial Innovations?

In today's fast-evolving landscape, artificial intelligence (AI) is reshaping a plethora of industries, notably the realm of clinical trials. AI promises enhanced efficiency, reduced costs, and improved outcomes for medical research. The integration of AI in medical research is stirring interest

Advancing Alzheimer's Treatments with Novel Drug Targets
Research & Development Advancing Alzheimer's Treatments with Novel Drug Targets

Amid rising prevalence and societal impact, addressing Alzheimer's disease demands breakthroughs in research and treatment. The pioneering initiative by the Indiana University School of Medicine, through the TREAT-AD (Target Enablement to Accelerate Therapy Development for Alzheimer's Disease) drug

Will FDA's Fast-Track Program Boost Drug Manufacturing?
Research & Development Will FDA's Fast-Track Program Boost Drug Manufacturing?

Amid growing health crises and increasing global competition in pharmaceuticals, a novel FDA initiative aims to fast-track drug reviews by slashing approval times for essential medicines. Can this new approach significantly impact domestic drug manufacturing, or does it introduce unprecedented

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later